EVERUS CONSTRUCTION GROUP (ECG) Fundamental Analysis & Valuation

NYSE:ECG • US3004261034

Current stock price

129.08 USD
-0.26 (-0.2%)
At close:
129.08 USD
0 (0%)
After Hours:

This ECG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ECG Profitability Analysis

1.1 Basic Checks

  • In the past year ECG was profitable.
  • ECG had a positive operating cash flow in the past year.
  • In the past 5 years ECG has always been profitable.
  • ECG had a positive operating cash flow in 4 of the past 5 years.
ECG Yearly Net Income VS EBIT VS OCF VS FCFECG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 100M 200M

1.2 Ratios

  • ECG has a better Return On Assets (11.67%) than 89.09% of its industry peers.
  • The Return On Equity of ECG (32.04%) is better than 85.45% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 19.28%, ECG belongs to the top of the industry, outperforming 85.45% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ECG is significantly above the industry average of 13.89%.
Industry RankSector Rank
ROA 11.67%
ROE 32.04%
ROIC 19.28%
ROA(3y)11.95%
ROA(5y)N/A
ROE(3y)32.18%
ROE(5y)N/A
ROIC(3y)19.3%
ROIC(5y)N/A
ECG Yearly ROA, ROE, ROICECG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • ECG has a better Profit Margin (5.39%) than 67.27% of its industry peers.
  • ECG's Profit Margin has improved in the last couple of years.
  • ECG has a Operating Margin of 7.07%. This is comparable to the rest of the industry: ECG outperforms 56.36% of its industry peers.
  • In the last couple of years the Operating Margin of ECG has grown nicely.
  • ECG has a Gross Margin of 12.12%. This is in the lower half of the industry: ECG underperforms 65.45% of its industry peers.
  • In the last couple of years the Gross Margin of ECG has grown nicely.
Industry RankSector Rank
OM 7.07%
PM (TTM) 5.39%
GM 12.12%
OM growth 3Y5.03%
OM growth 5YN/A
PM growth 3Y5.22%
PM growth 5YN/A
GM growth 3Y5.83%
GM growth 5YN/A
ECG Yearly Profit, Operating, Gross MarginsECG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 2 4 6 8 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. ECG Health Analysis

2.1 Basic Checks

  • ECG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, ECG has about the same amount of shares outstanding.
  • ECG has a better debt/assets ratio than last year.
ECG Yearly Shares OutstandingECG Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 10M 20M 30M 40M 50M
ECG Yearly Total Debt VS Total AssetsECG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 7.06 indicates that ECG is not in any danger for bankruptcy at the moment.
  • ECG has a better Altman-Z score (7.06) than 83.64% of its industry peers.
  • ECG has a debt to FCF ratio of 3.13. This is a good value and a sign of high solvency as ECG would need 3.13 years to pay back of all of its debts.
  • The Debt to FCF ratio of ECG (3.13) is better than 76.36% of its industry peers.
  • ECG has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
  • ECG has a Debt to Equity ratio of 0.42. This is comparable to the rest of the industry: ECG outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 3.13
Altman-Z 7.06
ROIC/WACC1.8
WACC10.74%
ECG Yearly LT Debt VS Equity VS FCFECG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • ECG has a Current Ratio of 1.76. This is a normal value and indicates that ECG is financially healthy and should not expect problems in meeting its short term obligations.
  • ECG has a better Current ratio (1.76) than 76.36% of its industry peers.
  • ECG has a Quick Ratio of 1.70. This is a normal value and indicates that ECG is financially healthy and should not expect problems in meeting its short term obligations.
  • ECG has a better Quick ratio (1.70) than 81.82% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.7
ECG Yearly Current Assets VS Current LiabilitesECG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ECG Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 40.52% over the past year.
  • The Earnings Per Share has been growing by 17.26% on average over the past years. This is quite good.
  • ECG shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.47%.
  • ECG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.55% yearly.
EPS 1Y (TTM)40.52%
EPS 3Y17.26%
EPS 5YN/A
EPS Q2Q%61.19%
Revenue 1Y (TTM)31.47%
Revenue growth 3Y11.55%
Revenue growth 5YN/A
Sales Q2Q%33.15%

3.2 Future

  • Based on estimates for the next years, ECG will show a small growth in Earnings Per Share. The EPS will grow by 7.99% on average per year.
  • The Revenue is expected to grow by 5.45% on average over the next years.
EPS Next Y6.77%
EPS Next 2Y7.97%
EPS Next 3Y10.96%
EPS Next 5Y7.99%
Revenue Next Year16.45%
Revenue Next 2Y12.38%
Revenue Next 3Y12.04%
Revenue Next 5Y5.45%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ECG Yearly Revenue VS EstimatesECG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
ECG Yearly EPS VS EstimatesECG Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

3

4. ECG Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 32.76, ECG can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, ECG is valued a bit cheaper than the industry average as 69.09% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.71. ECG is around the same levels.
  • The Price/Forward Earnings ratio is 30.68, which means the current valuation is very expensive for ECG.
  • Based on the Price/Forward Earnings ratio, ECG is valued a bit cheaper than 61.82% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.09, ECG is valued at the same level.
Industry RankSector Rank
PE 32.76
Fwd PE 30.68
ECG Price Earnings VS Forward Price EarningsECG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as ECG.
  • ECG's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 73.2
EV/EBITDA 22.87
ECG Per share dataECG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of ECG may justify a higher PE ratio.
PEG (NY)4.84
PEG (5Y)N/A
EPS Next 2Y7.97%
EPS Next 3Y10.96%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ECG Dividend Analysis

5.1 Amount

  • ECG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ECG Fundamentals: All Metrics, Ratios and Statistics

EVERUS CONSTRUCTION GROUP

NYSE:ECG (4/21/2026, 7:36:05 PM)

After market: 129.08 0 (0%)

129.08

-0.26 (-0.2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-24
Earnings (Next)05-11
Inst Owners86.93%
Inst Owner Change0.06%
Ins Owners0.33%
Ins Owner Change1.84%
Market Cap6.59B
Revenue(TTM)3.75B
Net Income(TTM)201.77M
Analysts76.36
Price Target131.84 (2.14%)
Short Float %3.04%
Short Ratio2.47
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.53%
Min EPS beat(2)39.23%
Max EPS beat(2)77.83%
EPS beat(4)4
Avg EPS beat(4)63.8%
Min EPS beat(4)39.23%
Max EPS beat(4)77.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)15.74%
Min Revenue beat(2)13.86%
Max Revenue beat(2)17.63%
Revenue beat(4)4
Avg Revenue beat(4)19.01%
Min Revenue beat(4)13.86%
Max Revenue beat(4)23.55%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)24.04%
PT rev (3m)21.08%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.9%
EPS NY rev (1m)0.24%
EPS NY rev (3m)6.59%
Revenue NQ rev (1m)0.59%
Revenue NQ rev (3m)5.5%
Revenue NY rev (1m)1.02%
Revenue NY rev (3m)6.04%
Valuation
Industry RankSector Rank
PE 32.76
Fwd PE 30.68
P/S 1.76
P/FCF 73.2
P/OCF 42
P/B 10.46
P/tB 13.54
EV/EBITDA 22.87
EPS(TTM)3.94
EY3.05%
EPS(NY)4.21
Fwd EY3.26%
FCF(TTM)1.76
FCFY1.37%
OCF(TTM)3.07
OCFY2.38%
SpS73.4
BVpS12.34
TBVpS9.53
PEG (NY)4.84
PEG (5Y)N/A
Graham Number33.0744 (-74.38%)
Profitability
Industry RankSector Rank
ROA 11.67%
ROE 32.04%
ROCE 26.67%
ROIC 19.28%
ROICexc 23.28%
ROICexgc 28.19%
OM 7.07%
PM (TTM) 5.39%
GM 12.12%
FCFM 2.4%
ROA(3y)11.95%
ROA(5y)N/A
ROE(3y)32.18%
ROE(5y)N/A
ROIC(3y)19.3%
ROIC(5y)N/A
ROICexc(3y)21.39%
ROICexc(5y)N/A
ROICexgc(3y)26.75%
ROICexgc(5y)N/A
ROCE(3y)26.71%
ROCE(5y)N/A
ROICexgc growth 3Y6.67%
ROICexgc growth 5YN/A
ROICexc growth 3Y8.88%
ROICexc growth 5YN/A
OM growth 3Y5.03%
OM growth 5YN/A
PM growth 3Y5.22%
PM growth 5YN/A
GM growth 3Y5.83%
GM growth 5YN/A
F-Score5
Asset Turnover2.17
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 3.13
Debt/EBITDA 0.91
Cap/Depr 232.07%
Cap/Sales 1.78%
Interest Coverage 13.43
Cash Conversion 53.43%
Profit Quality 44.61%
Current Ratio 1.76
Quick Ratio 1.7
Altman-Z 7.06
F-Score5
WACC10.74%
ROIC/WACC1.8
Cap/Depr(3y)192.28%
Cap/Depr(5y)175.68%
Cap/Sales(3y)1.58%
Cap/Sales(5y)1.48%
Profit Quality(3y)74.59%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.52%
EPS 3Y17.26%
EPS 5YN/A
EPS Q2Q%61.19%
EPS Next Y6.77%
EPS Next 2Y7.97%
EPS Next 3Y10.96%
EPS Next 5Y7.99%
Revenue 1Y (TTM)31.47%
Revenue growth 3Y11.55%
Revenue growth 5YN/A
Sales Q2Q%33.15%
Revenue Next Year16.45%
Revenue Next 2Y12.38%
Revenue Next 3Y12.04%
Revenue Next 5Y5.45%
EBIT growth 1Y39.41%
EBIT growth 3Y17.16%
EBIT growth 5YN/A
EBIT Next Year32.55%
EBIT Next 3Y20.44%
EBIT Next 5Y16.39%
FCF growth 1Y-21.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4%
OCF growth 3YN/A
OCF growth 5YN/A

EVERUS CONSTRUCTION GROUP / ECG Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EVERUS CONSTRUCTION GROUP?

ChartMill assigns a fundamental rating of 6 / 10 to ECG.


What is the valuation status for ECG stock?

ChartMill assigns a valuation rating of 3 / 10 to EVERUS CONSTRUCTION GROUP (ECG). This can be considered as Overvalued.


Can you provide the profitability details for EVERUS CONSTRUCTION GROUP?

EVERUS CONSTRUCTION GROUP (ECG) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for ECG stock?

The Price/Earnings (PE) ratio for EVERUS CONSTRUCTION GROUP (ECG) is 32.76 and the Price/Book (PB) ratio is 10.46.


Can you provide the financial health for ECG stock?

The financial health rating of EVERUS CONSTRUCTION GROUP (ECG) is 7 / 10.